LIP
AHCO icon

Liontrust Investment Partners’s AdaptHealth AHCO Stock Holding History

Liontrust Investment Partners’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,493
Closed -$385K – 211
2024
Q4 		$385K Buy
40,493
+16,855
+71% +$171K 0.01% 194
2024
Q3 		$236K Hold
23,638
– – ﹤0.01% 203
2024
Q2 		$236K Hold
23,638
– – ﹤0.01% 203
2024
Q1 		$272K Hold
23,638
– – ﹤0.01% 179
2023
Q4 		$172K Sell
23,638
-762
-3% -$6.01K ﹤0.01% 187
2023
Q3 		$222K Sell
24,400
-161,800
-87% -$1.94M ﹤0.01% 187
2023
Q2 		$2.27M Sell
186,200
-3,900
-2% -$43.5K 0.03% 175
2023
Q1 		$2.36M Buy
190,100
+25,300
+15% +$465K 0.03% 165
2022
Q4 		$3.17M Hold
164,800
– – 0.06% 118
2022
Q3 		$3.09M Hold
164,800
– – 0.05% 165
2022
Q2 		$2.97M Hold
164,800
– – 0.04% 178
2022
Q1 		$2.64M Hold
164,800
– – 0.03% 150
2021
Q4 		$4.03M Hold
164,800
– – 0.05% 139
2021
Q3 		$3.84M Buy
+164,800
New +$3.99M 0.05% 141

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Liontrust Investment Partners's AHCO Position: Q1 2025 in Review

Liontrust Investment Partners sold out of AdaptHealth (AHCO) in Q1 2025, closing a stake of 40,493 shares — an estimated $385K sold.

Liontrust Investment Partners first reported a position in AHCO in Q3 2021 and held it in 14 quarters. The position peaked at $4.03M in Q4 2021. 226 funds tracked by Wall St. Rank hold AHCO as of Q1 2025.

  • Liontrust Investment Partners reported no remaining AdaptHealth position as of Q1 2025 after selling out during the quarter.
  • Liontrust Investment Partners sold 40,493 AdaptHealth shares in Q1 2025, an estimated $385K.
  • Liontrust Investment Partners first reported a position in AdaptHealth in Q3 2021 and held it in 14 quarters.
  • Liontrust Investment Partners's AdaptHealth position peaked at $4.03M in Q4 2021.
  • 226 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2025.

Based on Liontrust Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.